These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23766264)

  • 1. PKCβ promotes vascular inflammation and acceleration of atherosclerosis in diabetic ApoE null mice.
    Kong L; Shen X; Lin L; Leitges M; Rosario R; Zou YS; Yan SF
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1779-87. PubMed ID: 23766264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Old suspect--new evidence: the role of PKCβ in diabetes mellitus-accelerated atherosclerosis.
    Butcher M; Galkina EV
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1737-8. PubMed ID: 23864722
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
    Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
    Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice.
    Bu DX; Rai V; Shen X; Rosario R; Lu Y; D'Agati V; Yan SF; Friedman RA; Nuglozeh E; Schmidt AM
    Circ Res; 2010 Apr; 106(6):1040-51. PubMed ID: 20133903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of NOX4 and NOX1 on immune cell-mediated inflammation in the aortic sinus of diabetic ApoE-/- mice.
    Di Marco E; Gray SP; Chew P; Kennedy K; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Clin Sci (Lond); 2016 Aug; 130(15):1363-74. PubMed ID: 27190136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) mice.
    Di Marco E; Gray SP; Chew P; Koulis C; Ziegler A; Szyndralewiez C; Touyz RM; Schmidt HH; Cooper ME; Slattery R; Jandeleit-Dahm KA
    Diabetologia; 2014 Mar; 57(3):633-42. PubMed ID: 24292634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis.
    Harja E; Chang JS; Lu Y; Leitges M; Zou YS; Schmidt AM; Yan SF
    FASEB J; 2009 Apr; 23(4):1081-91. PubMed ID: 19036858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.
    Soro-Paavonen A; Watson AM; Li J; Paavonen K; Koitka A; Calkin AC; Barit D; Coughlan MT; Drew BG; Lancaster GI; Thomas M; Forbes JM; Nawroth PP; Bierhaus A; Cooper ME; Jandeleit-Dahm KA
    Diabetes; 2008 Sep; 57(9):2461-9. PubMed ID: 18511846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A.
    Ge S; Hertel B; Koltsova EK; Sörensen-Zender I; Kielstein JT; Ley K; Haller H; von Vietinghoff S
    Circ Res; 2013 Sep; 113(8):965-74. PubMed ID: 23908345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.
    Rahaman SO; Li W; Silverstein RL
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2053-7. PubMed ID: 23825362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis.
    Ullevig SL; Zhao Q; Zamora D; Asmis R
    Atherosclerosis; 2011 Dec; 219(2):409-16. PubMed ID: 21752377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of the complement regulatory protein CD59 accelerates the development of diabetes-induced atherosclerosis in mice.
    Liu F; Sahoo R; Ge X; Wu L; Ghosh P; Qin X; Halperin JA
    J Diabetes Complications; 2017 Feb; 31(2):311-317. PubMed ID: 27729184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis.
    Shen J; Chandrasekharan UM; Ashraf MZ; Long E; Morton RE; Liu Y; Smith JD; DiCorleto PE
    Circ Res; 2010 Mar; 106(5):902-10. PubMed ID: 20093631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKC-β activation inhibits IL-18-binding protein causing endothelial dysfunction and diabetic atherosclerosis.
    Durpès MC; Morin C; Paquin-Veillet J; Beland R; Paré M; Guimond MO; Rekhter M; King GL; Geraldes P
    Cardiovasc Res; 2015 May; 106(2):303-13. PubMed ID: 25808972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell-mediated chronic low-grade inflammation is regulated by the RAGE-TLR4-PKCβ
    Zhao L; Li Y; Xu T; Lv Q; Bi X; Liu X; Fu G; Zou Y; Ge J; Chen Z; Zhang W
    Mol Med; 2022 Jan; 28(1):4. PubMed ID: 35062863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium-restricted endothelin-1 overexpression in type 1 diabetes worsens atherosclerosis and immune cell infiltration via NOX1.
    Ouerd S; Idris-Khodja N; Trindade M; Ferreira NS; Berillo O; Coelho SC; Neves MF; Jandeleit-Dahm KA; Paradis P; Schiffrin EL
    Cardiovasc Res; 2021 Mar; 117(4):1144-1153. PubMed ID: 32533834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction.
    Huang Q; Qin L; Dai S; Zhang H; Pasula S; Zhou H; Chen H; Min W
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):795-804. PubMed ID: 23413429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice.
    Lu Z; Zhang X; Li Y; Jin J; Huang Y
    J Endocrinol; 2013 Jan; 216(1):61-71. PubMed ID: 23060524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability.
    Seehaus S; Shahzad K; Kashif M; Vinnikov IA; Schiller M; Wang H; Madhusudhan T; Eckstein V; Bierhaus A; Bea F; Blessing E; Weiler H; Frommhold D; Nawroth PP; Isermann B
    Circulation; 2009 Sep; 120(9):774-84. PubMed ID: 19687358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.